In 1962, epidermal growth factor (EGF) was discovered by Dr. Stanley Cohen while studying
nerve growth factor (NGF). It was soon recognized that EGF is the prototypical member of a …

Mesenchymal stem/stromal cells (MSCs) are becoming increasingly important for the
development of cell therapeutics in regenerative medicine. Featuring immunomodulatory …

Following respiratory viral infection, regeneration of the epithelial barrier is required to
preserve lung function and prevent secondary infections. Lung regulatory T (Treg) cells are …

Production of amphiregulin (Areg) by regulatory T (Treg) cells promotes repair after acute
tissue injury. Here, we examined the function of Treg cells in non-alcoholic steatohepatitis …

Tumor microenvironment represents the site where the tumor tries to survive and escape
from immune system-mediated recognition. Indeed, to proliferate tumor cells can divert the …

Chronic myelogenous leukaemia (CML) is a clonal myeloproliferative disorder. Recent
evidence indicates that altered crosstalk between CML and mesenchymal stromal cells may …

Skin regeneration is an important area of research in the field of tissue-engineering,
especially for cases involving loss of massive areas of skin, where current treatments are not …

Hematopoietic stem/progenitor cells in the adult mammalian bone marrow ensure blood cell
renewal. Their cellular microenvironment, called 'niche', regulates hematopoiesis both under …

Aim To investigate the therapeutic effects and immunomodulatory mechanisms of human
placenta‐derived mesenchymal stem cells (PMSCs) in diabetic kidney disease (DKD) …

Introduction: Interleukin-6 (IL-6) can activate downstream signaling pathways in lung cancer
cells, such as the STAT3 pathway, and is reported to be produced by tumor cells with …